PATHWAY BIOPHARMA LIMITED
Executive Summary
Pathway Biopharma Limited currently exhibits a stable financial position with positive net assets and liquidity ratios, reflecting low solvency risk. The company complies with filing requirements and is managed by a single controlling director, indicating sound governance. However, the decline in net assets and limited operational scale suggest a need for closer scrutiny of financial trends and business prospects before investment.
View Full Analysis Report →Company Documents
| Date | Description |
|---|---|
| 18/04/2518 April 2025 | Micro company accounts made up to 2024-10-31 |
| 31/10/2431 October 2024 | Annual accounts for year ending 31 Oct 2024 |
| 30/10/2430 October 2024 | Confirmation statement made on 2024-10-18 with updates |
| 22/04/2422 April 2024 | Micro company accounts made up to 2023-10-31 |
| 29/11/2329 November 2023 | |
| 31/10/2331 October 2023 | Annual accounts for year ending 31 Oct 2023 |
| 30/10/2330 October 2023 | Confirmation statement made on 2023-10-18 with updates |
| 19/05/2319 May 2023 | Micro company accounts made up to 2022-10-31 |
| 31/10/2231 October 2022 | Annual accounts for year ending 31 Oct 2022 |
| 19/10/2219 October 2022 | Confirmation statement made on 2022-10-18 with updates |
| 16/10/2216 October 2022 | Confirmation statement made on 2022-10-13 with updates |
| 31/10/2131 October 2021 | Annual accounts for year ending 31 Oct 2021 |
| 22/10/2122 October 2021 | Confirmation statement made on 2021-10-13 with no updates |
| 14/10/2014 October 2020 | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
| 14/10/2014 October 2020 | Incorporation |
More Company Information
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company